11 recruiting, 2 active not recruiting, 1 completed, 1 terminated. 6 Phase 2, 4 Not applicable, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 4, Terminated 1, Withdrawn 1 |
| Not applicable | 4 | Recruiting 4 |
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
Follow Prostate Cancers: new trials by email Literature Review of Prostate Cancers trials Research Report on Prostate Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRostate Cancer Enhanced Diagnosis by Calibration Technology MRI - Prostate Cancers | Recruiting | Gold Standard Phantoms | 66 | 2026-06-26 | 2026-09-09 | |
| Using FAPI PET/MRI to Evaluate Prostate Cancer FAPI, Positron Emission Tomography (PET), Magnetic Resonance Imaging - Prostate Cancer Metastatic Disease, Prostate Cancers | Phase 2 | Recruiting | University of Wisconsin, Madison | 30 | 2026-02-27 | 2026-06-10 |
| The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling DiNanoQ: A multi-cancer early detection (MCED) blood test, DiNanoTrack: Therapeutic Response Monitoring Blood Test - Brest Cancer, Lung Cancer (NSCLC) | Recruiting | Javier Toledo | 6000 | 2025-12-20 | 2026-01-02 | |
| To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery. Prostate Cancers, Breast Cancer | Recruiting | XEOS Medical | 850 | 2025-11-19 | 2026-09-15 | |
| Early Phase Study of KESONOTIDE™in Participants With Solid Tumours A novel hGIIA-Vimentin Inhibitor, Dose expansion - Prostate Cancers, Breast Cancer | Phase 1 / Phase 2 | Recruiting | Filamon LTD | 80 | 2025-11-07 | 2026-03-17 |
| A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations ATV-1601, ATV-1601 + Fulvestrant - Advanced Solid Tumors, Breast Cancer | Phase 1 | Active not recruiting | Atavistik Bio, Inc | 134 | 2025-07-29 | 2026-08-07 |
| Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial surgery - Prostate Cancer (Adenocarcinoma), Prostate Cancer (Post Prostatectomy) | Not applicable | Recruiting | East and North Hertfordshire NHS Trust | 100 | 2025-04-22 | 2026-07-08 |
| Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada Group Exercise Classes - Cancer, Prostate Cancers | Not applicable | Recruiting | University of Calgary | 740 | 2025-03-11 | 2025-10-07 |
| Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0. Extended Pelvic Lymph Node Dissection - Prostate Cancer Surgery, Prostate Cancers | Not applicable | Recruiting | University Hospital, Basel, Switzerland | 400 | 2025-02-10 | 2025-07-03 |
| Ivonescimab in the Treatment of Multiple Advanced Tumors Ivocizumab - Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma | Phase 2 | Recruiting | Fudan University | 400 | 2024-11-20 | 2025-08-24 |
| FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer FK-PC101, Standard of Care (SOC) - Prostate Cancer (Adenocarcinoma), Prostate CA | Phase 2 | Recruiting | Cellvax Therapeutics Inc | 100 | 2024-10-14 | 2024-10-21 |
| Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen One single intravenous injection of [177Lu]Lu-BQ7876 - Prostate Cancers | Phase 1 | Completed | Tomsk National Research Medical Center of the Russian Academy of Sciences | 7 | 2024-10-01 | 2026-06-26 |
| Comprehensive Outcomes for After Cancer Health Digital Health Coaching Program, Fitbit - Ovarian Cancer, Breast Cancer | Not applicable | Recruiting | Pack Health | 625 | 2022-06-23 | 2024-12-11 |
| Effectiveness, Safety, and Economic Evaluation of Goserelin Microspheres for Injection and Goserelin Sustained-Release Implants in Prostate Cancer Patients: A Real-World Study Prostate Cancers | Active not recruiting | Qianfoshan Hospital | 400 | 2020-04-02 | 2025-04-16 | |
| Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management 68Ga-(HBED-CC)-PSMA - Prostate Cancers | Phase 2 | Withdrawn | Jules Bordet Institute | 2016-10-01 | 2017-08-22 | |
| FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cancer anti [18F]FACBC - Prostate Cancers | Phase 2 | Terminated | David M. Schuster, MD | 11 | 2008-04-01 | 2014-01-07 |
Prostatic Neoplasms (16) · Breast Neoplasms (5) · Lung Neoplasms (4) · Neoplasms (4) · Ovarian Neoplasms (4) · Adenocarcinoma (2) · Endometrial Neoplasms (2) · Glioblastoma (2) · Head and Neck Neoplasms (2) · Motor Activity (2) · Angiomyolipoma (1) · Breast Diseases (1) · Carcinoma (1) · Carcinoma, Basal Cell (1) · Carcinoma, Hepatocellular (1)
Genital Diseases (16) · Genital Diseases, Male (16) · Genital Neoplasms, Male (16) · Male Urogenital Diseases (16) · Prostatic Diseases (16) · Urogenital Diseases (16) · Neoplasms by Site (15) · Urogenital Neoplasms (15) · Neoplasms (12) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Neoplasms by Histologic Type (5) · Neoplasms, Glandular and Epithelial (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5)
68Ga-DKFZ-PSMA-11 (1) · Fulvestrant (1) · Hematologic Tests (1) · Magnetic Resonance Spectroscopy (1) · Standard of Care (1) · Surgical Procedures, Operative (1) · fluciclovine F-18 (1) · gallium 68 PSMA-11 (1)
Atavistik Bio, Inc (1) · Cellvax Therapeutics Inc (1) · David M. Schuster, MD (1) · East and North Hertfordshire NHS Trust (1) · Filamon LTD (1) · Fudan University (1) · Gold Standard Phantoms (1) · Javier Toledo (1) · Jules Bordet Institute (1) · Pack Health (1) · Qianfoshan Hospital (1) · Tomsk National Research Medical Center of the Russian Academy of Sciences (1) · University Hospital, Basel, Switzerland (1) · University of Calgary (1) · University of Wisconsin, Madison (1)
United States (5) · United Kingdom (4) · China (2) · Argentina (1) · Australia (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Netherlands (1) · Nigeria (1) · Russia (1) · Singapore (1) · Spain (1) · Switzerland (1)
Alexi Wright, MD (1) · Ali Pirasteh, MD (1) · Anneliese Gonzalez, MD (1) · Carlos Artigas, MD (1) · David M Schuster, MD (1) · Debra E Lyon, PhD (1) · Elizabeth Arthur, PhD (1) · Fernando Kreutz, MD PhD (1) · Hongxia Wang, Doctor (1) · Javier Toledo, Medical Degree (1) · Jessica Krok-Schoen, PhD (1) · Kathrin Milbury, PhD (1) · Kristen Fessele, PhD (1) · Marilyn Hammer, PhD (1) · Nicole Culos-Reed, PhD (1)
ZIANR000020-06 (1)